Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial

Article ID	Journal	Published Year	Pages	File Type
5959352	Heart Rhythm	2016	8 Pages	PDF

Abstract

Adding lines to wide antral PVI in substrate-based AF requires significantly more ablation, increases procedure duration and radiation dose, but provides no additional clinical benefit.

Keywords

AAD PeAF WACA PVI CTI RCT Quality of life Randomized controlled trial Pulmonary vein isolation ITT Atrial substrate Atrial tachycardia Ablation antiarrhythmic drug pulmonary vein cavotricuspid isthmus Outcomes confidence interval persistent atrial fibrillation Atrial fibrillation Paroxysmal atrial fibrillation intention-to-treat odds ratio PAF Clinical trial

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial

Authors

Gareth J. MB ChB, MRCP, MD(Res), Sandeep MBBS, MRCP, Maureen RN, Mark MD, FRCP, Johan MD, FRCP, Vias MD, FRCP, Wajid MB ChB, MRCP, Tushar MD(Res), MRCP, Simon MBBS, MRCP, Julian MA, MBBS, MRCP, MD(Res), David G. MBBS, MD, Richard MD, MRCP, Derick MD,